Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Febrile Neutropenia × Tazobactam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Other Infectious Diseases 1 Neoplasms 1 Febrile Neutropenia 1

Interventions

Meropenem 3 Levofloxacin 3 Ceftazidime 3 pegfilgrastim 2 Interleukin 1 Receptor Antagonist Protein 2 Filgrastim 2 Ciprofloxacin 2 Cefepime 2 Anti-Bacterial Agents 2 Amoxicillin-Potassium Clavulanate Combination 2 Amikacin 2 pegylated granulocyte colony-stimulating factor 1 Vancomycin 1 Therapeutics 1 Tazobactam 1 TKN732 1 Surveys and Questionnaires 1 Positron Emission Tomography Computed Tomography 1 Piperacillin 1 NF protocol 1 Micafungin 1 Magnetic Resonance Myelography 1 Lead 1 Injections 1 Cloxacillin 1 Caspofungin 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡